SCHEMBL1816288

SCHEMBL1816288

COCCCOc1cc(CC(CC2C(CC(C(=O)NCC(C)(C)C(N)=O)C(C)C)OCN2C(=O)O)C(C)C)ccc1OC

nearest known ligand 0.62

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
REN P00797 20/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14351532 1.00 REN (0.62) REN
SCHEMBL1820519 1.00 REN (0.62) REN
SCHEMBL12234422 1.00 REN (0.62) REN
SCHEMBL1819522 1.00 REN (0.62) REN
SCHEMBL1823236 1.00 REN (0.62) REN
SCHEMBL1821821 1.00 REN (0.62) REN
SCHEMBL1823232 1.00 REN (0.62) REN
SCHEMBL1820521 1.00 REN (0.62) REN
SCHEMBL12234371 0.95 REN (0.61) REN
SCHEMBL12239118 0.95 REN (0.57) REN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2499120-A1 NOVEL 1,3-OXAZOLIDINE COMPOUNDS AND THEIR USE AS RENIN INHIBITORS Novadex Pharmaceuticals AB (SE) 2012-09-19 EP disclosed
WO-2011056126-A1 NOVEL 1,3-OXAZOLIDINE COMPOUNDS AND THEIR USE AS RENIN INHIBITORS NOVADEX PHARMACEUTICALS AB (SE) 2011-05-12 WO disclosed